Last update:

Parkinson's & Movement disorders news

Genetics

New genetic test targets elusive cause of rare movement disorder

Scientists at Brigham and Women's Hospital and Harvard Medical School have developed a targeted genetic test to improve diagnosis for X-linked dystonia-parkinsonism (XDP), a rare and disabling movement disorder that affects ...

Neuroscience

Drug candidate slows motor neuron disease progression and preserves muscle function in preclinical study

A drug candidate found to protect nerve cells damaged by motor neuron disease (MND), could offer new hope to people living with the devastating condition.

Neuroscience

Removing toxic proteins before they can damage motor neurons

University of Wollongong (UOW) scientists have developed a breakthrough therapy that clears toxic proteins from nerve cells—a discovery that advances the work of the late Professor Justin Yerbury and could transform the ...

Parkinson's & Movement disorders

Personalized care can ease Parkinson's pain

Every 27 minutes, someone in Australia is diagnosed with Parkinson's disease. Best known for its tremors, movement and balance issues, it also brings another, often overlooked burden—persistent pain.

Neuroscience

New electrical signature of Parkinson's disease identified

What happens in the brain when a person experiences the characteristic movement symptoms of Parkinson's disease? Researchers around the world are seeking answers through various approaches. One of these builds on a treatment ...

Genetics

Common genetic causes across motor neuron diseases identified

Motor neuron diseases, such as amyotrophic lateral sclerosis (ALS) and hereditary spastic paraplegia (HSP), share physical similarities but have been largely viewed as genetically distinct. However, an analysis led by investigators ...

Parkinson's & Movement disorders

Advancement for people with Parkinson's in light therapy trial

Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled trial (RCT) demonstrating improvements in a range of Parkinson's disease symptoms. These results, ...

Neuroscience

Burden of pain significantly higher in Parkinson's patients

A major QIMR Berghofer-led study has found that Australians living with Parkinson's disease are nearly three times more likely to suffer from chronic pain compared to the general community, with two-thirds of patients experiencing ...

Neuroscience

How fruit flies can help us understand diseases such as ALS

If we can understand exactly how neurodegenerative diseases such as ALS progress in fruit flies, we may also gain valuable insights into how these diseases develop in humans. Research by neurobiologist Marije Been of Radboud ...

Parkinson's & Movement disorders

Mouth and gut bacteria linked to brain changes in Parkinson's disease

Scientists have discovered a link between bacteria in the mouth and gut and the progression of cognitive decline in Parkinson's disease. Specific changes in these bacteria, known as the microbiome, have been associated with ...

Medications

Asthma drug could help to treat a rare neurological disorder

The asthma medication theophylline is a suitable drug for treating the rare neurological disorder ADCY5-related dyskinesia, according to a new study by Martin Luther University Halle-Wittenberg (MLU), which was published ...

Autism spectrum disorders

Autism linked to elevated risk of Parkinson's disease

People with an autism diagnosis are at a higher risk of developing Parkinson's disease early in life, a large-scale study from Karolinska Institutet published in JAMA Neurology reports. The researchers believe that the two ...

Genetics

Diagnosing Parkinson's using a blood-based genetic signature

Parkinson's disease is best known for its effects on the central nervous system. In addition, recent scientific advances generally emphasize the role of the immune system in the presence and development of the disease.

Medications

Trend toward survival benefit seen for REM-inhibition in ALS

For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a trend toward survival benefit, according to a study presented at the ...